Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate
@article{Pu2005DualsubtypeFV, title={Dual-subtype FIV vaccine (Fel-O-Vax{\textregistered} FIV) protection against a heterologous subtype B FIV isolate}, author={Ruiyu Pu and James K. Coleman and James G Coisman and Eiji Sato and Taishi Tanabe and Maki Arai and Janet K. Yamamoto}, journal={Journal of Feline Medicine and Surgery}, year={2005}, volume={7}, pages={65 - 70} }
Figures from this paper
57 Citations
Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge
- Medicine, BiologyJournal of feline medicine and surgery
- 2010
Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
- BiologyVaccine
- 2014
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
- BiologyCurrent HIV research
- 2010
Findings from these studies are being used to define the prophylactic epitopes needed for an HIV-1 vaccine for humans.
Vaccine protection against feline immunodeficiency virus: setting the challenge.
- Medicine, Political ScienceAustralian veterinary journal
- 2007
The challenges facing vaccine development, the current state of knowledge and future prospects for FIV vaccination are reviewed.
Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
- BiologyVeterinary microbiology
- 2007
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan.
- Medicine, BiologyThe Journal of veterinary medical science
- 2010
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection was conducted in Japan and a geographic distribution of four subtypes (A, B, C and D) of FIV in Japan was disclosed.
Limited efficacy of an inactivated feline immunodeficiency virus vaccine
- BiologyVeterinary Record
- 2006
The vaccine is licensed in the USA, Canada and Australia for use in cats over eight weeks of age, and has been shown to provide protection against a number of FIV isolates, including those of subtypes A, B and C.
Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
- Medicine, BiologyAIDS
- 2007
This data indicates that FIV infection in cats is a natural infection of domestic felid populations which results in a chronic and progressive acquired immunodeficiency syndrome and that vaccination against FIV is a viable treatment option for these patients.
Sequence variation of the feline immunodeficiency virus genome and its clinical relevance
- BiologyVeterinary Record
- 2013
It is important that the key determinants of immunity induced by this vaccine are discovered; such data would compliment vaccine field efficacy studies and provide the basis to make informed recommendations on its use.
References
SHOWING 1-10 OF 20 REFERENCES
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
- Biology, MedicineAIDS
- 2001
Dual-subtype vaccinated cats developed broad-spectrum humoral and cellular immunity which protected cats against in vivo-derived inocula of homologous and heterologous FIV subtypes, suggesting an increase in cytotoxic cell activities against AIDS viruses.
FIV vaccine development and its importance to veterinary and human medicine: a review
- Biology, MedicineVeterinary Immunology and Immunopathology
- 2002
Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
- BiologyVaccine
- 2004
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
- BiologyThe Journal of general virology
- 1999
The results of the present study are discussed in the light of enhancement of lentiv virus infections as a complicating factor in lentivirus vaccine development.
Enhancement after feline immunodeficiency virus vaccination.
- BiologyVeterinary immunology and immunopathology
- 1992
Vaccination with Inactivated Virus but Not Viral DNA Reduces Virus Load following Challenge with a Heterologous and Virulent Isolate of Feline Immunodeficiency Virus
- BiologyJournal of Virology
- 2000
Results indicate that the more virulent FIVGL8 is intrinsically more resistant to vaccinal immunity than the FIVPET strain and that a broad spectrum of responses which includes virus neutralizing antibodies is a desirable goal for lentivirus vaccine development.
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades
- BiologyJournal of virology
- 1997
Analysis of all available FIV env sequences revealed the existence of recombinant viruses generated from subtype A/B, B/D, and A/C envelope gene sequences, consistent with the hypothesis that Fiv-B is an older virus group and is possibly more host adapted than FIV-A.
Feline bone marrow transplantation: its use in FIV-infected cats.
- Biology, MedicineVeterinary immunology and immunopathology
- 1998
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
- BiologyJournal of Molecular Evolution
- 2005
Some examples were worked out using reported globin sequences to show that synonymous substitutions occur at much higher rates than amino acid-altering substitutions in evolution.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
- BiologyMolecular biology and evolution
- 1987
The neighbor-joining method and Sattath and Tversky's method are shown to be generally better than the other methods for reconstructing phylogenetic trees from evolutionary distance data.